1.   Besedovsky HO, del Rey AE, Sorkin E. What do the immune system and the brain know about each other? Immunol Today 1983; 4:342-346.

2.   Chrousos GP. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med 1995; 332(20):1351-1362.

3.   Elenkov IJ, Wilder RL, Chrousos GP, Vizi ES. The sympathetic nerve-an integrative interface between two supersystems: the brain and the immune system. Pharmacol Rev 2000; 52(4):595-638.

4.   Mosmann TR, Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 1996; 17(3):138-146.

5.   Fearon DT, Locksley RM. The instructive role of innate immunity in the acquired immune response. Science 1996; 272(5258):50-53.

6.   Trinchieri G. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu Rev Immunol 1995; 13:251-276.

7.   Kastelein RA, Hunter CA, Cua DJ. Discovery and biology of IL-23 and IL-27: related but functionally distinct regulators of inflammation. Annu Rev Immunol 2007; 25:221-242.

8.   Romagnani S. Human Th17 cells. Arthritis Res Ther 2008; 10(2):206.

9.   Beutler B, Krochin N, Milsark IW, Luedke C, Cerami A. Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance. Science 1986; 232:977-980.

10.   Boumpas DT, Chrousos GP, Wilder RL, Cupps TR, Balow JE. Glucocorticoid therapy for immune-mediated diseases: basic and clinical correlates. Ann Intern Med 1993; 119(12):1198-1208.

11.   Elenkov IJ, Papanicolaou DA, Wilder RL, Chrousos GP. Modulatory effects of glucocorticoids and catecholamines on human interleukin-12 and interleukin-10 production: clinical implications. Proc Assoc Am Physicians 1996; 108(5):374-381.

12.   Blotta MH, DeKruyff RH, Umetsu DT. Corticosteroids inhibit IL-12 production in human monocytes and enhance their capacity to induce IL-4 synthesis in CD4+ lymphocytes. J Immunol 1997; 158(12):5589-5595.

13.   DeKruyff RH, Fang Y, Umetsu DT. Corticosteroids enhance the capacity of macrophages to induce Th2 cytokine synthesis in CD4+ lymphocytes by inhibiting IL-12 production. J Immunol 1998; 160(5):2231-2237.

14.   Wu CY, Wang K, McDyer JF, Seder RA. Prostaglandin E2 and dexamethasone inhibit IL-12 receptor expression and IL-12 responsiveness. J Immunol 1998; 161(6):2723-2730.

15.   Ramierz F, Fowell DJ, Puklavec M, Simmonds S, Mason D. Glucocorticoids promote a TH2 cytokine response by CD4+ T cells in vitro. J Immunol 1996; 156(7):2406-2412.

16.   van der Poll T, Barber AE, Coyle SM, Lowry SF. Hypercortisolemia increases plasma interleukin-10 concentrations during human endotoxemia--a clinical research center study. J Clin Endocrinol Metab 1996; 81(10):3604-3606.

17.   Panina-Bordignon P, Mazzeo D, Lucia PD et al. Beta2-agonists prevent Th1 development by selective inhibition of interleukin 12. J Clin Invest 1997; 100(6):1513-1519.

18.   Hasko G, Szabo C, Nemeth ZH, Salzman AL, Vizi ES. Stimulation of beta-adrenoceptors inhibits endotoxin-induced IL-12 production in normal and IL-10 deficient mice. J Neuroimmunol 1998; 88(1-2):57-61.

19.   Hetier E, Ayala J, Bousseau A, Prochiantz A. Modulation of interleukin-1 and tumor necrosis factor expression by beta-adrenergic agonists in mouse ameboid microglial cells. Exp Brain Res 1991; 86:407-413.

20.   Severn A, Rapson NT, Hunter CA, Liew FY. Regulation of tumor necrosis factor production by adrenaline and -adrenergic agonists. J Immunol 1992; 148:3441-3445.

21.   Nakamura A, Johns EJ, Imaizumi A, Abe T, Kohsaka T. Regulation of tumour necrosis factor and interleukin-6 gene transcription by beta2-adrenoceptor in the rat astrocytes. J Neuroimmunol 1998; 88:144-153.

22.   Koff WC, Fann AV, Dunegan MA, Lachman LB. Catecholamine-induced suppression of interleukin-1 production. Lymphokine Res 1986; 5:239-247.

23.   van der Poll T, Lowry SF. Epinephrine inhibits endotoxin-induced IL-1 beta production: roles of tumor necrosis factor-alpha and IL-10. Am J Physiol 1997; 273(6 Pt 2):R1885-R1890.

24.   van der Poll T, Coyle SM, Barbosa K, Braxton CC, Lowry SF. Epinephrine inhibits tumor necrosis factor-alpha and potentiates interleukin 10 production during human endotoxemia. J Clin Invest 1996; 97(3):713-719.

25.   Norris JG, Benveniste EN. Interleukin-6 production by astrocytes: induction by the neurotransmitter norepinephrine. J Neuroimmunol 1993; 45:137-145.

26.   Maimone D, Cioni C, Rosa S, Macchia G, Aloisi F, Annunziata P. Norepinephrine and vasoactive intestinal peptide induce IL-6 secretion by astrocytes: synergism with IL-1 beta and TNF alpha. J Neuroimmunol 1993; 47:73-81.

27.   Sanders VM, Baker RA, Ramer-Quinn DS, Kasprowicz DJ, Fuchs BA, Street NE. Differential expression of the beta2-adrenergic receptor by Th1 and Th2 clones: implications for cytokine production and B cell help. J Immunol 1997; 158(9):4200-4210.

28.   Borger P, Hoekstra Y, Esselink MT et al. Beta-adrenoceptor-mediated inhibition of IFN-gamma, IL-3, and GM-CSF mRNA accumulation in activated human T lymphocytes is solely mediated by the beta2-adrenoceptor subtype. Am J Respir Cell Mol Biol 1998; 19(3):400-407.

29.   Coqueret O, Lagente V, Frere CP, Braquet P, Mencia-Huerta JM. Regulation of IgE production by beta 2-adrenoceptor agonists. Ann N Y Acad Sci 1994; 725:44-49.

30.   Elenkov IJ, Kvetnansky R, Hashiramoto A et al. Low- versus high-baseline epinephrine output shapes opposite innate cytokine profiles: presence of Lewis- and Fischer-like neurohormonal immune phenotypes in humans? J Immunol 2008; 181(3):1737-1745.

31.   Felten DL, Felten SY, Carlson SL, Olschowka JA, Livnat S. Noradrenergic and peptidergic innervation of lymphoid tissue. J Immunol 1985; 135(2 Suppl):755s-765s.

32.   Lundberg JM, Rudehill A, Sollevi A, Fried G, Wallin G. Co-release of neuropeptide Y and noradrenaline from pig spleen in vivo: importance of subcellular storage, nerve impulse frequency and pattern, feedback regulation and resupply by axonal transport. Neuroscience 1989; 28(2):475-486.

33.   Straub RH, Herrmann M, Frauenholz T et al. Neuroimmune control of interleukin-6 secretion in the murine spleen. Differential beta-adrenergic effects of electrically released endogenous norepinephrine under various endotoxin conditions. J Neuroimmunol 1996; 71:37-43.

34.   Bedoui S, Kawamura N, Straub RH, Pabst R, Yamamura T, von Horsten S. Relevance of Neuropeptide Y for the neuroimmune crosstalk. J Neuroimmunol 2003; 134(1-2):1-11.

35.   Burnstock G. The past, present and future of purine nucleotides as signalling molecules. Neuropharmacology 1997; 36(9):1127-1139.

36.   Westfall DP, Todorov LD, Mihaylova-Todorova ST. ATP as a cotransmitter in sympathetic nerves and its inactivation by releasable enzymes. J Pharmacol Exp Ther 2002; 303(2):439-444.

37.   Sperlagh B, Doda M, Baranyi M, Hasko G. Ischemic-like condition releases norepinephrine and purines from different sources in superfused rat spleen strips. J Neuroimmunol 2000; 111(1-2):45-54.

38.   Hasko G, Kuhel DG, Salzman AL, Szabo C. ATP suppression of interleukin-12 and tumour necrosis factor-alpha release from macrophages. Br J Pharmacol 2000; 129(5):909-914.

39.   Wilkin F, Stordeur P, Goldman M, Boeynaems JM, Robaye B. Extracellular adenine nucleotides modulate cytokine production by human monocyte-derived dendritic cells: dual effect on IL-12 and stimulation of IL-10. Eur J Immunol 2002; 32(9):2409-2417.

40.   la Sala A, Ferrari D, Corinti S, Cavani A, Di Virgilio F, Girolomoni G. Extracellular ATP induces a distorted maturation of dendritic cells and inhibits their capacity to initiate Th1 responses. J Immunol 2001; 166(3):1611-1617.

41.   Schnurr M, Toy T, Shin A, Wagner M, Cebon J, Maraskovsky E. Extracellular nucleotide signaling by P2 receptors inhibits IL-12 and enhances IL-23 expression in human dendritic cells: a novel role for the cAMP pathway. Blood 2005; 105(4):1582-1589.

42.   Perregaux DG, McNiff P, Laliberte R, Conklyn M, Gabel CA. ATP acts as an agonist to promote stimulus-induced secretion of IL-1 beta and IL-18 in human blood. J Immunol 2000; 165(8):4615-4623.

43.   Chakfe Y, Seguin R, Antel JP et al. ADP and AMP induce interleukin-1beta release from microglial cells through activation of ATP-primed P2X7 receptor channels. J Neurosci 2002; 22(8):3061-3069.

44.   Matzinger P. The danger model: a renewed sense of self. Science 2002; 296(5566):301-305.

45.   Gallucci S, Matzinger P. Danger signals: SOS to the immune system. Curr Opin Immunol 2001; 13(1):114-119.

46.   Cronstein BN, Naime D, Ostad E. The antiinflammatory mechanism of methotrexate. Increased adenosine release at inflamed sites diminishes leukocyte accumulation in an in vivo model of inflammation. J Clin Invest 1993; 92(6):2675-2682.

47.   Cronstein BN, Rosenstein ED, Kramer SB, Weissmann G, Hirschhorn R. Adenosine; a physiologic modulator of superoxide anion generation by human neutrophils. Adenosine acts via an A2 receptor on human neutrophils. J Immunol 1985; 135(2):1366-1371.

48.   Lappin D, Riches DW, Damerau B, Whaley K. Cyclic nucleotides and their relationship to complement-component-C2 synthesis by human monocytes. Biochem J 1984; 222(2):477-486.

49.   Link AA, Kino T, Worth JA et al. Ligand-activation of the adenosine A2a receptors inhibits IL-12 production by human monocytes. J Immunol 2000; 164(1):436-442.

50.   Prabhakar U, Brooks DP, Lipshlitz D, Esser KM. Inhibition of LPS-induced TNF alpha production in human monocytes by adenosine (A2) receptor selective agonists. Int J Immunopharmacol 1995; 17(3):221-224.

51.   Le Moine O, Stordeur P, Schandene L et al. Adenosine enhances IL-10 secretion by human monocytes. J Immunol 1996; 156(11):4408-4414.

52.   Hasko G, Szabo C, Nemeth ZH, Kvetan V, Pastores SM, Vizi ES. Adenosine receptor agonists differentially regulate IL-10, TNF-alpha, and nitric oxide production in RAW 264.7 macrophages and in endotoxemic mice. J Immunol 1996; 157:4634-4640.

53.   Deshpande R, Khalili H, Pergolizzi RG, Michael SD, Chang MD. Estradiol down-regulates LPS-induced cytokine production and NFkB activation in murine macrophages. Am J Reprod Immunol 1997; 38(1):46-54.

54.   Elenkov IJ, Wilder RL, Bakalov VK et al. IL-12, TNF-alpha, and hormonal changes during late pregnancy and early postpartum: implications for autoimmune disease activity during these times. J Clin Endocrinol Metab 2001; 86(10):4933-4938.

55.   Correale J, Arias M, Gilmore W. Steroid hormone regulation of cytokine secretion by proteolipid protein-specific CD4+ T cell clones isolated from multiple sclerosis patients and normal control subjects. J Immunol 1998; 161(7):3365-3374.

56.   Gilmore W, Weiner LP, Correale J. Effect of estradiol on cytokine secretion by proteolipid protein-specific T cell clones isolated from multiple sclerosis patients and normal control subjects. J Immunol 1997; 158(1):446-451.

57.   Zang YC, Halder JB, Hong J, Rivera VM, Zhang JZ. Regulatory effects of estriol on T cell migration and cytokine profile: inhibition of transcription factor NF-kappa B. J Neuroimmunol 2002 Mar ;124 (1 -2 ):106 -14 124(1-2):106-114.

58.   Kanda N, Tsuchida T, Tamaki K. Estrogen enhancement of anti-double-stranded DNA antibody and immunoglobulin G production in peripheral blood mononuclear cells from patients with systemic lupus erythematosus. Arthritis Rheum 1999; 42(2):328-337.

59.   Chao TC, Van Alten PJ, Greager JA, Walter RJ. Steroid sex hormones regulate the release of tumor necrosis factor by macrophages. Cell Immunol 1995; 160(1):43-49.

60.   Siracusa MC, Overstreet MG, Housseau F, Scott AL, Klein SL. 17beta-estradiol alters the activity of conventional and IFN-producing killer dendritic cells. J Immunol 2008; 180(3):1423-1431.

61.   Miller L, Hunt JS. Regulation of TNF-alpha production in activated mouse macrophages by progesterone. J Immunol 1998; 160(10):5098-5104.

62.   Piccinni MP, Giudizi MG, Biagiotti R et al. Progesterone favors the development of human T helper cells producing Th2-type cytokines and promotes both IL-4 production and membrane CD30 expression in established Th1 cell clones. J Immunol 1995; 155(1):128-133.

63.   Chrousos GP, Torpy DJ, Gold PW. Interactions between the hypothalamic-pituitary-adrenal axis and the female reproductive system: clinical implications. Ann Intern Med 1998; 129(3):229-240.

64.   Vamvakopoulos NC, Chrousos GP. Evidence of direct estrogenic regulation of human corticotropin-releasing hormone gene expression. Potential implications for the sexual dimophism of the stress response and immune/inflammatory reaction. J Clin Invest 1993; 92(4):1896-1902.

65.   Salt PJ. Inhibition of noradrenaline uptake 2 in the isolated rat heart by steroids, clonidine and methoxylated phenylethylamines. Eur J Pharmacol 1972; 20(3):329-340.

66.   Cenci S, Weitzmann MN, Roggia C et al. Estrogen deficiency induces bone loss by enhancing T-cell production of TNF-alpha. J Clin Invest 2000 Nov ;106 (10 ):1229 -37 106(10):1229-1237.

67.   Roggia C, Gao Y, Cenci S et al. Up-regulation of TNF-producing T cells in the bone marrow: a key mechanism by which estrogen deficiency induces bone loss in vivo. Proc Natl Acad Sci U S A 2001 Nov 20 ;98 (24 ):13960 -5 98(24):13960-13965.

68.   Srivastava S, Toraldo G, Weitzmann MN, Cenci S, Ross FP, Pacifici R. Estrogen decreases osteoclast formation by down-regulating receptor activator of NF-kappa B ligand (RANKL)-induced JNK activation. J Biol Chem 2001 Mar 23 ;276 (12 ):8836 -40 276(12):8836-8840.

69.   Lemire J. 1,25-Dihydroxyvitamin D3--a hormone with immunomodulatory properties. Z Rheumatol 2000 ;59 Suppl 1 :24 -7 59 Suppl 1:24-27.

70.   D'Ambrosio D, Cippitelli M, Cocciolo MG et al. Inhibition of IL-12 production by 1,25-dihydroxyvitamin D3. Involvement of NF-kappaB downregulation in transcriptional repression of the p40 gene. J Clin Invest 1998; 101(1):252-262.

71.   Lemire JM, Archer DC, Beck L, Spiegelberg HL. Immunosuppressive actions of 1,25-dihydroxyvitamin D3: preferential inhibition of Th1 functions. J Nutr 1995; 125(6 Suppl):1704S-1708S.

72.   Penna G, Adorini L. 1 Alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J Immunol 2000 Mar 1 ;164 (5 ):2405 -11 164(5):2405-2411.

73.   Rausch-Fan X, Leutmezer F, Willheim M et al. Regulation of cytokine production in human peripheral blood mononuclear cells and allergen-specific th cell clones by 1alpha,25-dihydroxyvitamin D3. Int Arch Allergy Immunol 2002 May ;128 (1 ):33 -41 128(1):33-41.

74.   Mattner F, Smiroldo S, Galbiati F et al. Inhibition of Th1 development and treatment of chronic-relapsing experimental allergic encephalomyelitis by a non-hypercalcemic analogue of 1,25-dihydroxyvitamin D(3). Eur J Immunol 2000 Feb ;30 (2 ):498 -508 30(2):498-508.

75.   Gregori S, Giarratana N, Smiroldo S, Uskokovic M, Adorini L. A 1alpha,25-dihydroxyvitamin D(3) analog enhances regulatory T-cells and arrests autoimmune diabetes in NOD mice. Diabetes 2002 May ;51 (5 ):1367 -74 51(5):1367-1374.

76.   Kang S, Yi S, Griffiths CE, Fancher L, Hamilton TA, Choi JH. Calcipotriene-induced improvement in psoriasis is associated with reduced interleukin-8 and increased interleukin-10 levels within lesions. Br J Dermatol 1998; 138(1):77-83.

77.   Falus A, Meretey K. Histamine: an early messenger in inflammatory and immune reactions. Immunol Today 1992; 13(5):154-156.

78.   Vannier E, Miller LC, Dinarello CA. Histamine suppresses gene expression and synthesis of tumor necrosis factor alpha via histamine H2 receptors. J Exp Med 1991; 174(1):281-284.

79.   Vannier E, Dinarello CA. Histamine enhances interleukin (IL)-1-induced IL-6 gene expression and protein synthesis via H2 receptors in peripheral blood mononuclear cells. J Biol Chem 1994; 269(13):9952-9956.

80.   Elenkov IJ, Webster E, Papanicolaou DA, Fleisher TA, Chrousos GP, Wilder RL. Histamine potently suppresses human IL-12 and stimulates IL-10 production via H2 receptors. J Immunol 1998; 161(5):2586-2593.

81.   Idzko M, la Sala A, Ferrari D et al. Expression and function of histamine receptors in human monocyte-derived dendritic cells. J Allergy Clin Immunol 2002 May ;109 (5 ):839 -46 109(5):839-846.

82.   Lagier B, Lebel B, Bousquet J, Pene J. Different modulation by histamine of IL-4 and interferon-gamma (IFN- gamma) release according to the phenotype of human Th0, Th1 and Th2 clones. Clin Exp Immunol 1997; 108(3):545-551.

83.   Lotz M, Vaughan JH, Carson DA. Effect of neuropeptides on production of inflammatory cytokines by human monocytes. Science 1988; 241:1218-1221.

84.   Kincy-Cain T, Bost KL. Substance P-induced IL-12 production by murine macrophages. J Immunol 1997; 158:2334-2339.

85.   Ho WZ, Stavropoulos G, Lai JP et al. Substance P C-terminal octapeptide analogues augment tumor necrosis factor-alpha release by human blood monocytes and macrophages. J Neuroimmunol 1998; 82:126-132.

86.   Fox FE, Kubin M, Cassin M et al. Calcitonin gene-related peptide inhibits proliferation and antigen presentation by human peripheral blood mononuclear cells: effects on B7, interleukin 10, and interleukin 12. J Invest Dermatol 1997; 108(1):43-48.

87.   Liu J, Chen M, Wang X. Calcitonin gene-related peptide inhibits lipopolysaccharide-induced interleukin-12 release from mouse peritoneal macrophages, mediated by the cAMP pathway. Immunology 2000; 101(1):61-67.

88.   Ganea D, Delgado M. Inhibitory neuropeptide receptors on macrophages. Microbes Infect 2001; 3(2):141-147.

89.   Maier SF, Goehler LE, Fleshner M, Watkins LR. The role of the vagus nerve in cytokine-to-brain communication. Ann N Y Acad Sci 1998; 840:289-300.

90.   Fleshner M, Silbert L, Deak T et al. TNF-alpha-induced corticosterone elevation but not serum protein or corticosteroid binding globulin reduction is vagally mediated. Brain Res Bull 1997; 44(6):701-706.

91.   Watkins LR, Goehler LE, Relton JK et al. Blockade of interleukin-1 induced hyperthermia by subdiaphragmatic vagotomy: evidence for vagal mediation of immune-brain communication. Neurosci Lett 1995; 183(1-2):27-31.

92.   Borovikova LV, Ivanova S, Zhang M et al. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 2000; 405(6785):458-462.

93.   Tracey KJ. The inflammatory reflex. Nature 2002; 420(6917):853-859.

94.   Ganea D, Gonzalez-Rey E, Delgado M. A novel mechanism for immunosuppression: from neuropeptides to regulatory T cells. J Neuroimmune Pharmacol 2006; 1(4):400-409.

95.   Naseer T, Minshall EM, Leung DY et al. Expression of IL-12 and IL-13 mRNA in asthma and their modulation in response to steroid therapy. Am J Respir Crit Care Med 1997; 155(3):845-851.

96.   Bentley AM, Hamid Q, Robinson DS et al. Prednisolone treatment in asthma. Reduction in the numbers of eosinophils, T cells, tryptase-only positive mast cells, and modulation of IL-4, IL-5, and interferon-gamma cytokine gene expression within the bronchial mucosa. Am J Respir Crit Care Med 1996; 153(2):551-556.

97.   Bradding P, Feather IH, Wilson S, Holgate ST, Howarth PH. Cytokine immunoreactivity in seasonal rhinitis: regulation by a topical corticosteroid. Am J Respir Crit Care Med 1995; 151(6):1900-1906.

98.   Batuman OA, Ferrero A, Cupp C, Jimenez SA, Khalili K. Differential regulation of transforming growth factor beta-1 gene expression by glucocorticoids in human T and glial cells. J Immunol 1995; 155(9):4397-4405.

99.   Broug-Holub E, Kraal G. Dose- and time-dependent activation of rat alveolar macrophages by glucocorticoids. Clin Exp Immunol 1996; 104(2):332-336.

100.   Spengler RN, Allen RM, Remick DG, Strieter RM, Kunkel SL. Stimulation of -adrenergic receptor augments the production of macrophage-derived tumor necrosis factor. J Immunol 1990; 145:1430-1434.

101.   Le Tulzo Y, Shenkar R, Kaneko D et al. Hemorrhage increases cytokine expression in lung mononuclear cells in mice: involvement of catecholamines in nuclear factor-kappaB regulation and cytokine expression. J Clin Invest 1997; 99(7):1516-1524.

102.   Broug-Holub E, Persoons JH, Schornagel K, Mastbergen SC, Kraal G. Effects of stress on alveolar macrophages: a role for the sympathetic nervous system. Am J Respir Cell Mol Biol 1998; 19(5):842-848.

103.   Kavelaars A, van dP, Zijlstra J, Heijnen CJ. Beta 2-adrenergic activation enhances interleukin-8 production by human monocytes. J Neuroimmunol 1997; 77(2):211-216.

104.   Linden A. Increased interleukin-8 release by beta-adrenoceptor activation in human transformed bronchial epithelial cells. Br J Pharmacol 1996; 119(2):402-406.

105.   Engstad CS, Lund T, Osterud B. Epinephrine promotes IL-8 production in human leukocytes via an effect on platelets. Thromb Haemost 1999; 81(1):139-145.

106.   Kaplanski G, Porat R, Aiura K, Erban JK, Gelfand JA, Dinarello CA. Activated platelets induce endothelial secretion of interleukin-8 in vitro via an interleukin-1-mediated event. Blood 1993; 81(10):2492-2495.

107.   Mohamed-Ali V, Flower L, Sethi J et al. beta-Adrenergic regulation of IL-6 release from adipose tissue: in vivo and in vitro studies. J Clin Endocrinol Metab 2001; 86(12):5864-5869.

108.   Vicennati V, Vottero A, Friedman C, Papanicolaou DA. Hormonal regulation of interleukin-6 production in human adipocytes. Int J Obes Relat Metab Disord 2002; 26(7):905-911.

109.   Baumann H, Gauldie J. The acute phase response. Immunol Today 1994; 15(2):74-80.

110.   Li Y, Chi L, Stechschulte DJ, Dileepan KN. Histamine-induced production of interleukin-6 and interleukin-8 by human coronary artery endothelial cells is enhanced by endotoxin and tumor necrosis factor-alpha. Microvasc Res 2001; 61(3):253-262.

111.   Murray DR, Prabhu SD, Chandrasekar B. Chronic beta-adrenergic stimulation induces myocardial proinflammatory cytokine expression. Circulation 2000; 101(20):2338-2341.

112.   Karalis K, Sano H, Redwine J, Listwak S, Wilder RL, Chrousos GP. Autocrine or paracrine inflammatory actions of corticotropin-releasing hormone in vivo. Science 1991; 254(5030):421-423.

113.   Elenkov IJ, Webster EL, Torpy DJ, Chrousos GP. Stress, corticotropin-releasing hormone, glucocorticoids, and the immune/inflammatory response: acute and chronic effects. Ann N Y Acad Sci 1999; 876:1-11.

114.   Udelsman R, Gallucci WT, Bacher J, Loriaux DL, Chrousos GP. Hemodynamic effects of corticotropin releasing hormone in the anesthetized cynomolgus monkey. Peptides 1986; 7(3):465-471.

115.   Theoharides TC, Singh LK, Boucher W et al. Corticotropin-releasing hormone induces skin mast cell degranulation and increased vascular permeability, a possible explanation for its proinflammatory effects. Endocrinology 1998; 139(1):403-413.

116.   Foreman JC. Substance P and calcitonin gene-related peptide: effects on mast cells and in human skin. Int Arch Allergy Appl Immunol 1987; 82:366-371.

117.   Church MK, Lowman MA, Robinson C, Holgate ST, Benyon RC. Interaction of neuropeptides with human mast cells. Int Arch Allergy Appl Immunol 1989; 88:70-78.

118.   Theoharides TC, Spanos C, Pang X et al. Stress-induced intracranial mast cell degranulation: a corticotropin- releasing hormone-mediated effect. Endocrinology 1995; 136(12):5745-5750.

119.   Girndt M, Sester U, Kaul H, Hunger F, Kohler H. Glucocorticoids inhibit activation-dependent expression of costimulatory molecule B7-1 in human monocytes. Transplantation 1998; 66(3):370-375.

120.   Pan J, Ju D, Wang Q et al. Dexamethasone inhibits the antigen presentation of dendritic cells in MHC class II pathway. Immunol Lett 2001; 76(3):153-161.

121.   Clavreul A, D'hellencourt CL, Montero-Menei C, Potron G, Couez D. Vitamin D differentially regulates B7.1 and B7.2 expression on human peripheral blood monocytes. Immunology 1998; 95(2):272-277.

122.   Galon J, Franchimont D, Hiroi N et al. Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells. FASEB J 2002; 16(1):61-71.

123.   Benschop RJ, Rodriguez-Feuerhahn M, Schedlowski M. Catecholamine-induced leukocytosis: early observations, current research, and future directions. Brain Behav Immun 1996; 10(2):77-91.

124.   Maisel AS, Michel MC. Beta-adrenoceptor control of immune function in congestive heart failure. Br J Clin Pharmacol 1990; 30 Suppl 1:49S-53S.

125.   Hadden JW, Hadden EM, Middleton EJr. Lymphocyte blast transformation I. Demonstration of adrenergic receptors in human peripheral lymphocytes. Cell Immunol 1970; 1:583-595.

126.   Chambers DA, Cohen RL, Perlman RL. Neuroimmune modulation: signal transduction and catecholamines. Neurochem Int 1993; 22(2):95-110.

127.   Elliott L, Brooks W, Roszman T. Inhibition of anti-CD3 monoclonal antibody-induced T-cell proliferation by dexamethasone, isoproterenol, or prostaglandin E2 either alone or in combination. Cell Mol Neurobiol 1992; 12(5):411-427.

128.   Carlson SL, Brooks WH, Roszman TL. Neurotransmitter-lymphocyte interactions: dual receptor modulation of lymphocyte proliferation and cAMP production. J Neuroimmunol 1989; 24(1-2):155-162.

129.   Bartik MM, Bauman GP, Brooks WH, Roszman TL. Costimulatory signals modulate the antiproliferative effects of agents that elevate cAMP in T cells. Cell Immunol 1994; 158(1):116-130.

130.   Wheway J, Mackay CR, Newton RA et al. A fundamental bimodal role for neuropeptide Y1 receptor in the immune system. J Exp Med 2005; 202(11):1527-1538.

131.   Sanders VM, Munson AE. Norepinephrine and the antibody response. Pharmacol Rev 1985; 37:229-248.

132.   Coqueret O, Dugas B, Mencia-Huerta JM, Braquet P. Regulation of IgE production from human mononuclear cells by beta 2-adrenoceptor agonists. Clin Exp Allergy 1995; 25(4):304-311.

133.   Coqueret O, Lagente V, Frere CP, Braquet P, Mencia-Huerta JM. Regulation of IgE production by beta 2-adrenoceptor agonists. Ann N Y Acad Sci 1994; 725:44-49.

134.   Wu CY, Sarfati M, Heusser C et al. Glucocorticoids increase the synthesis of immunoglobulin E by interleukin 4-stimulated human lymphocytes. J Clin Invest 1991; 87(3):870-877.

135.   Zieg G, Lack G, Harbeck RJ, Gelfand EW, Leung DY. In vivo effects of glucocorticoids on IgE production. J Allergy Clin Immunol 1994; 94(2 Pt 1):222-230.

136.   Elenkov IJ, Chrousos GP. Stress Hormones, Th1/Th2 patterns, Pro/Anti-inflammatory Cytokines and Susceptibility to Disease. Trends Endocrinol Metab 1999; 10(9):359-368.

137.   Wilder RL. Neuroendocrine-immune system interactions and autoimmunity. Annu Rev Immunol 1995; 13:307-338.

138.   Altare F, Durandy A, Lammas D et al. Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency. Science 1998; 280(5368):1432-1435.

139.   Lerner BH. Can stress cause disease? Revisiting the tuberculosis research of Thomas Holmes, 1949-1961. Ann Intern Med 1996; 124(7):673-680.

140.   Levenstein S, Ackerman S, Kiecolt-Glaser JK, Dubois A. Stress and peptic ulcer disease. JAMA 1999; 281(1):10-11.

141.   Cohen S, Tyrrell DA, Smith AP. Psychological stress and susceptibility to the common cold. N Engl J Med 1991; 325(9):606-612.

142.   Cole SW, Korin YD, Fahey JL, Zack JA. Norepinephrine accelerates HIV replication via protein kinase A- dependent effects on cytokine production. J Immunol 1998; 161(2):610-616.

143.   Cole SW, Naliboff BD, Kemeny ME, Griswold MP, Fahey JL, Zack JA. Impaired response to HAART in HIV-infected individuals with high autonomic nervous system activity. Proc Natl Acad Sci U S A 2001; 98(22):12695-12700.

144.   Kino T, Gragerov A, Kopp JB, Stauber RH, Pavlakis GN, Chrousos GP. The HIV-1 virion-associated protein vpr is a coactivator of the human glucocorticoid receptor [In Process Citation]. J Exp Med 1999; 189(1):51-62.

145.   Mirani M, Elenkov I, Volpi S, Hiroi N, Chrousos GP, Kino T. HIV-1 protein Vpr suppresses IL-12 production from human monocytes by enhancing glucocorticoid action: potential implications of Vpr coactivator activity for the innate and cellular immunity deficits observed in HIV-1 infection. J Immunol 2002; 169(11):6361-6368.

146.   Rook GA, Lightman SL, Heijnen CJ. Can nerve damage disrupt neuroendocrine immune homeostasis? Leprosy as a case in point. Trends Immunol 2002; 23(1):18-22.

147.   O'Sullivan ST, Lederer JA, Horgan AF, Chin DH, Mannick JA, Rodrick ML. Major injury leads to predominance of the T helper-2 lymphocyte phenotype and diminished interleukin-12 production associated with decreased resistance to infection. Ann Surg 1995; 222(4):482-490.

148.   Woiciechowsky C, Asadullah K, Nestler D et al. Sympathetic activation triggers systemic interleukin-10 release in immunodepression induced by brain injury [In Process Citation]. Nat Med 1998; 4(7):808-813.

149.   Elenkov IJ, Chrousos GP, Wilder RL. Neuroendocrine regulation of IL-12 and TNF-alpha/IL-10 balance. Clinical implications. Ann N Y Acad Sci 2000; 917:94-105.

150.   Meduri GU. New rationale for glucocorticoid treatment in septic shock. J Chemother 1999; 11(6):541-550.

151.   Meduri GU, Tolley EA, Chrousos GP, Stentz F. Prolonged methylprednisolone treatment suppresses systemic inflammation in patients with unresolving acute respiratory distress syndrome: evidence for inadequate endogenous glucocorticoid secretion and inflammation-induced immune cell resistance to glucocorticoids. Am J Respir Crit Care Med 2002; 165(7):983-991.

152.   Munford RS, Tracey KJ. Is severe sepsis a neuroendocrine disease? Mol Med 2002; 8(8):437-442.

153.   Wilder RL. Neuroendocrine-immune system interactions and autoimmunity. Annu Rev Immunol 1995; 13:307-338.

154.   Straub RH, Cutolo M. Involvement of the hypothalamic--pituitary--adrenal/gonadal axis and the peripheral nervous system in rheumatoid arthritis: viewpoint based on a systemic pathogenetic role. Arthritis Rheum 2001; 44(3):493-507.

155.   Miller LE, Justen HP, Scholmerich J, Straub RH. The loss of sympathetic nerve fibers in the synovial tissue of patients with rheumatoid arthritis is accompanied by increased norepinephrine release from synovial macrophages. FASEB J 2000; 14(13):2097-2107.

156.   Elenkov IJ, Hoffman J, Wilder RL. Does differential neuroendocrine control of cytokine production govern the expression of autoimmune diseases in pregnancy and the postpartum period? Mol Med Today 1997; 3(9):379-383.

157.   Barnes P, FitzGerald G, Brown M, Dollery C. Nocturnal asthma and changes in circulating epinephrine, histamine, and cortisol. N Engl J Med 1980; 303(5):263-267.

158.   Marshall GD, Jr., Agarwal SK. Stress, immune regulation, and immunity: applications for asthma. Allergy Asthma Proc 2000; 21(4):241-246.

159.   Colombo MP, Vagliani M, Spreafico F et al. Amount of interleukin 12 available at the tumor site is critical for tumor regression. Cancer Res 1996; 56(11):2531-2534.

160.   Chouaib S, Asselin-Paturel C, Mami-Chouaib F, Caignard A, Blay JY. The host-tumor immune conflict: from immunosuppression to resistance and destruction. Immunol Today 1997; 18(10):493-497.

161.   Shakhar G, Ben-Eliyahu S. In vivo beta-adrenergic stimulation suppresses natural killer activity and compromises resistance to tumor metastasis in rats. J Immunol 1998; 160:3251-3258.

162.   Li T, Harada M, Tamada K, Abe K, Nomoto K. Repeated restraint stress impairs the antitumor T cell response through its suppressive effect on Th1-type CD4+ T cells. Anticancer Res 1997; 17(6D):4259-4268.

163.   Matsumoto S. Cimetidine and survival with colorectal cancer [letter; comment]. Lancet 1995; 346(8967):115.

164.   Blay J, White TD, Hoskin DW. The extracellular fluid of solid carcinomas contains immunosuppressive concentrations of adenosine. Cancer Res 1997; 57(13):2602-2605.

165.   Hoskin DW, Reynolds T, Blay J. Adenosine as a possible inhibitor of killer T-cell activation in the microenvironment of solid tumours. Int J Cancer 1994; 59(6):854-855.